Valued at over $1.2 billion in 2006 this market will grow at a compound annual growth rate (CAGR) of more than 6% over the forecast period.
The global market for nuclear medicine systems comprises single photon emission computed tomography (SPECT) systems and positron emission tomography (PET)systems in the US, Europe, and Japan.